Exklusiver Live-Stream direkt von der World of Trading - 2 Tage mit einzigartigen Themen und Experten. Kostenlos teilnehmen + Videos erhalten. -w-
16.05.2018 22:01:00

ViewRay to Present at the UBS Global Healthcare Conference

CLEVELAND, May 16, 2018 /PRNewswire/ -- ViewRay®, Inc. (NASDAQ: VRAY) announced today that Chris Raanes, Chief Executive Officer, and Ajay Bansal, Chief Financial Officer, are scheduled to present at the UBS Global Healthcare Conference in New York, NY.

Event:                

UBS Global Healthcare Conference

Date:   

Tuesday, May 22, 2018

Time:    

3:00pm ET

 (PRNewsfoto/ViewRay, Inc.)

An audio webcast of the Company's presentation will be available on the investor relations section of ViewRay's website at www.viewray.com. A replay of the webcast will be available for 7 days after the date of the presentation.

About ViewRay
ViewRay®, Inc. (Nasdaq: VRAY), designs, manufactures and markets the MRIdian® radiation therapy system. MRIdian is built upon a proprietary high-definition MR imaging system designed from the ground up to address the unique challenges and clinical workflow for advanced radiation oncology. Unlike MR systems used in diagnostic radiology, MRIdian's high-definition MR was purposely built to deliver high-precision radiation without unnecessary beam distortion, and consequently, help to mitigate skin toxicity and other safety concerns that may otherwise arise when high magnetic fields interact with radiation beams. ViewRay and MRIdian are registered trademarks of ViewRay, Inc.

Cision View original content with multimedia:http://www.prnewswire.com/news-releases/viewray-to-present-at-the-ubs-global-healthcare-conference-300648510.html

SOURCE ViewRay, Inc.

Nachrichten zu ViewRay Incmehr Nachrichten

Keine Nachrichten verfügbar.

Analysen zu ViewRay Incmehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

ViewRay Inc 0,02 -33,33% ViewRay Inc